Ambulatory management of primary spontaneous pneumothorax

Duffy, Aleksandra; Ward, Janice; Bhatnagar, Malvika; Aujayeb, Avinash

doi:10.1183/20734735.0342-2020

Cited by 1 publication

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At present, simple bullectomy and bullectomy combined with pleural fixation are the main thoracoscopic surgical methods in the treatment of patients with PSP. In view of the potential risk of bleeding and tissue damage from pleural fixation, employing pleural fixation to reduce postoperative recurrence rate remains a controversy [4] . However, numerous studies have reported that pleural fixation has been used in the treatment of patients with PSP, resulting in good prognosis [5] .…”

Section: Discussionmentioning

confidence: 99%

“…The risk of pneumothorax increases with smoking. Other risk factors include cocaine use, family history of pneumothorax, and surrounding environment [4][5][6] . Secondary spontaneous pneumothorax (SSP) often occurs in patients with underlying lung diseases, such as chronic obstructive pulmonary disease, cystic fibrosis, lung cancer (primary or metastatic), pulmonary tuberculosis, pneumoconiosis, and intrathoracic endometriosis [7,8] .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer and Its Relationship with Tumor Markers

Liu

Zhang

2022

PAR

View full text Add to dashboard Cite

Objective: To explore the level of circulating tumor cells in patients with non-small cell lung cancer and its relationship with tumor markers. Methods: Fifty patients with NSCLC admitted to a hospital from March 2019 to February 2022 were retrospectively selected as the research subjects; their clinical data were sorted out and analyzed. All patients were examined for CTCs. According to their levels, the patients were divided into a positive group (30 cases, ? 4%) and a negative group (20 cases, < 4%). The positive rate of peripheral CTCs in patients with different gender, age, and pathological types of NSCLC, the positive rate of peripheral CTCs in patients with different staging of NSCLC, and the relationship between serum CEA, CA125, CYFRA21-1, and peripheral CTCs were analyzed and observed. Results: There was no significant difference in gender, age, and pathological type between the positive group and the negative group. There was also no significant difference in the T staging, N staging, and M staging between the positive group and the negative group. However, there was significant difference in the clinical staging of the positive group and the negative group. The CEA, CA125, and CYFRA21-1 of the positive group were 7.45 ± 1.26, 38.56 ± 4.12, and 5.01 ± 1.36, respectively, whereas those of the negative group were 5.12 ± 1.22, 32.69 ± 4.01, and 3.87 ± 1.25, respectively. The comparison between the two groups was statistically significant. Conclusion: CTCs provide the possibility of detecting cancer before the use of imaging methods, guide treatment in combination with other tumor markers, monitor postoperative treatment, and predict patients’ outcome.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%